Bank Of America Corp Pulmonx Corp Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Pulmonx Corp stock. As of the latest transaction made, Bank Of America Corp holds 34,779 shares of LUNG stock, worth $220,498. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,779

Previous 35,647 2.43%

Holding current value

$220,498

Previous $226,000 27.43%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.59 - $8.58 $4,852 - $7,447	-868 Reduced 2.43%	34,779 $288,000
Q2 2024 Aug 14, 2024	BUY	$5.77 - $9.82 $120,062 - $204,334	20,808 Added 140.23%	35,647 $226,000
Q1 2024 May 15, 2024	SELL	$8.71 - $14.65 $215,476 - $362,426	-24,739 Reduced 62.51%	14,839 $137,000
Q4 2023 Feb 14, 2024	SELL	$7.89 - $13.14 $208,240 - $346,804	-26,393 Reduced 40.01%	39,578 $504,000
Q2 2023 Aug 14, 2023	SELL	$10.78 - $13.65 $142,339 - $180,234	-13,204 Reduced 16.68%	65,971 $864,000
Q1 2023 May 12, 2023	SELL	$7.49 - $12.54 $17,564 - $29,406	-2,345 Reduced 2.88%	79,175 $885,000
Q4 2022 Feb 10, 2023	BUY	$4.92 - $17.35 $71,522 - $252,216	14,537 Added 21.7%	81,520 $687,000
Q3 2022 Nov 14, 2022	BUY	$15.35 - $23.99 $187,270 - $292,678	12,200 Added 22.27%	66,983 $1.12 Million
Q2 2022 Aug 12, 2022	BUY	$14.0 - $27.95 $41,776 - $83,402	2,984 Added 5.76%	54,783 $806,000
Q1 2022 May 16, 2022	BUY	$21.13 - $35.65 $676,413 - $1.14 Million	32,012 Added 161.78%	51,799 $1.29 Million
Q4 2021 Feb 08, 2022	BUY	$29.72 - $45.1 $72,576 - $110,134	2,442 Added 14.08%	19,787 $634,000
Q3 2021 Nov 15, 2021	SELL	$35.98 - $44.48 $405,998 - $501,912	-11,284 Reduced 39.41%	17,345 $623,000
Q2 2021 Sep 13, 2021	BUY	$37.61 - $48.0 $1.08 Million - $1.37 Million	28,629 New	28,629 $1.26 Million

Others Institutions Holding LUNG

# of Institutions

123

Shares Held

31M

Call Options Held

300

Put Options Held

204K

View Full List

About Pulmonx Corp

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

More about LUNG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Pulmonx Corp Transaction History